The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1H-Indol-3-yl)-2-[2-(2-1H-indol-2-yl-acetylamino)-propionylamino]-N-phenethyl-propionamide ID: ALA3144490
PubChem CID: 90663957
Max Phase: Preclinical
Molecular Formula: C32H33N5O3
Molecular Weight: 535.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](NC(=O)Cc1cc2ccccc2[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCc1ccccc1
Standard InChI: InChI=1S/C32H33N5O3/c1-21(35-30(38)19-25-17-23-11-5-7-13-27(23)36-25)31(39)37-29(18-24-20-34-28-14-8-6-12-26(24)28)32(40)33-16-15-22-9-3-2-4-10-22/h2-14,17,20-21,29,34,36H,15-16,18-19H2,1H3,(H,33,40)(H,35,38)(H,37,39)/t21-,29-/m0/s1
Standard InChI Key: ISILZFKHIMGFCX-LGGPFLRQSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
4.0331 -5.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8138 -9.8881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6831 -4.7756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0036 -7.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6708 -10.5778 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2737 -8.3290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9918 -9.8177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4308 -6.0864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1133 -6.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0838 -8.4849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8433 -5.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6239 -7.8613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0009 -10.6916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3539 -9.2645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8644 -4.8776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9235 -6.6140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7085 -5.6878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2945 -11.1179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1935 -7.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5437 -6.9258 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5732 -7.0817 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4340 -8.0172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3539 -7.0817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8940 -6.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1640 -5.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7232 -11.0903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2408 -4.3376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9290 -5.9578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6534 -8.0172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3104 -11.9427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6239 -5.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9741 -5.2108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8940 -4.2753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7391 -11.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3053 -5.4177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4612 -4.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0327 -12.3413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4340 -3.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5142 -4.5872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2442 -3.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 14 1 0
3 1 1 0
4 19 1 0
5 7 1 0
6 4 1 0
7 2 2 0
8 1 2 0
9 11 1 0
10 6 1 0
11 1 1 0
12 10 1 0
13 2 1 0
10 14 1 6
15 3 1 0
16 9 1 0
17 8 1 0
18 13 2 0
19 16 1 0
20 4 2 0
21 9 2 0
22 12 2 0
23 12 1 0
24 23 1 0
25 31 1 0
26 13 1 0
27 15 1 0
28 17 1 0
19 29 1 6
30 18 1 0
31 24 1 0
32 25 2 0
33 25 1 0
34 26 2 0
35 28 2 0
36 27 2 0
37 34 1 0
38 33 2 0
39 32 1 0
40 38 1 0
17 15 2 0
35 36 1 0
5 18 1 0
30 37 2 0
39 40 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 535.65Molecular Weight (Monoisotopic): 535.2583AlogP: 3.78#Rotatable Bonds: 11Polar Surface Area: 118.88Molecular Species: NEUTRALHBA: 3HBD: 5#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.43CX Basic pKa: ┄CX LogP: 3.74CX LogD: 3.74Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.18Np Likeness Score: -0.53
References 1. Weber D, Berger C, Eickelmann P, Antel J, Kessler H.. (2003) Design of selective peptidomimetic agonists for the human orphan receptor BRS-3., 46 (10): [PMID:12723954 ] [10.1021/jm0210921 ]